- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
National Diagnostics to merge with AES
Brandon, FL-based imaging services chain National Diagnostics has signed a definitive agreement to merge with integrated delivery system firm American Enterprise Solutions of Tampa, FL. Under the terms of the agreement, NDI shareholders will maintain a
Brandon, FL-based imaging services chain National Diagnostics has signed a definitive agreement to merge with integrated delivery system firm American Enterprise Solutions of Tampa, FL. Under the terms of the agreement, NDI shareholders will maintain a 12.3% interest in the new company, with AES shareholders holding an 87.7% interest. The combined company will have projected 1998 pre-tax profits of $4.5 million on revenues of roughly $46 million, according to the firms.
NDI agreed to the merger after suffering financial difficulties related to the company's rapid expansion. NDI had fallen behind on payments to vendors and lessors, and the firm's stock was delisted from the NASDAQ exchange in August 1997. AES was founded in September 1997 with the goal of acquiring companies to create community healthcare delivery systems.
In other NDI news, Jugal Taneja has resigned his post as chairman and CEO. COO Curtis Alliston has assumed the role of acting CEO.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
